الإحصائيات الأساسية
| CIK | 727672 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to SpectraScience, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| November 27, 2017 |
SCIE / SpectraSCIENCE, Inc. 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| November 14, 2017 |
SCIE / SpectraSCIENCE, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| November 7, 2017 |
SCIE / SpectraSCIENCE, Inc. 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| August 14, 2017 |
SCIE / SpectraSCIENCE, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| August 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| July 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| May 22, 2017 |
SpectraSCIENCE (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction (I.R.S. Employer of incorpor |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 33-24138-D CUSIP NUMBER 45247F 104 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11 |
|
| May 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| April 25, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| March 31, 2017 |
SpectraSCIENCE (Annual Report) 10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, I |
|
| February 24, 2017 |
SCIE / SpectraSCIENCE, Inc. / GPL Ventures, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SPECTRASCIENCE, INC.. (Name of Issuer) Common Stock (Title of Class of Securities) 84760E301 (CUSIP Number) February 14, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| January 23, 2017 |
DEF 14C 1 def14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. |
|
| January 18, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2017 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction (Commission (I.R.S. Employer o |
|
| January 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| November 14, 2016 |
Exhibit 3.6 SPECTRASCIENCE, INC AMENDED BYLAWS ARTICLE I OFFICERS, CORPORATE SEAL AND SHAREHOLDER CONTROL AGREEMENT SECTION 1.01. REGISTERED AND OTHER OFFICES. The registered office of the corporation in Minnesota shall be that set forth in the Articles of Incorporation or statement of the Board of Directors filed with the Secretary of State of Minnesota changing the registered office in the manne |
|
| November 14, 2016 |
AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. EX-3.3 4 ex3-3.htm Exhibit 3.3 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), hereby certifies as follows: The members of the Board of Directors have adopted a resolution amending Section 2.01 of the Amended and Restated Articles of Incorporation |
|
| November 14, 2016 |
AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. EX-3.5 6 ex3-5.htm Exhibit 3.5 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), hereby certifies as follows: The members of the Board of Directors have adopted a resolution amending Section 2.01 of the Amended and Restated Articles of Incorporation |
|
| November 14, 2016 |
CERTIFICATE OF CREATION OF SERIES A PREFERRED STOCK SPECTRASCIENCE, INC. Exhibit 3.7 CERTIFICATE OF CREATION OF SERIES A PREFERRED STOCK OF SPECTRASCIENCE, INC. I, James Hitchin, Chief Executive Officer of SpectraScience, Inc. a Minnesota corporation (the ?Company?), do hereby certify that on June 12, 2007, under the authority of Article II, Section 2.01 of the Company?s Amended and Restated Articles of Incorporation, the Board of Directors of the Company unanimously a |
|
| November 14, 2016 |
AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. Exhibit 3.4 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the ?Company?), hereby certifies as follows: The members of the Board of Directors have adopted a resolution amending Section 2.01 of the Amended and Restated Articles of Incorporation of the Company, an |
|
| November 14, 2016 |
EX-3.8 9 ex3-8.htm Exhibit 3.8 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), in accordance with the provisions of Minneso |
|
| November 14, 2016 |
SpectraSCIENCE (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction (I.R.S. Employer of inco |
|
| November 14, 2016 |
CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. Exhibit 3.2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. The undersigned, being the Chief Executive Officer of SpectraScience, Inc., a Minnesota corporation (the ?Corporation?), in accordance with the Minnesota Business Corporation Act, does hereby certify that the Board of Directors adopted the following resolutions effective as of September 21, 2009: AMENDMENT TO |
|
| November 14, 2016 |
Exhibit 3.9 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES C PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the ?Company?), in accordance with the provisions of Minnesota Statutes, Sectio |
|
| November 14, 2016 |
EX-3.10 11 ex3-10.htm Exhibit 3.10 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES AA, NON-TRANSFERRABLE, SUPER VOTING, PREFERRED STOCK OF SPECTRASCIENCE, INC. SpectraScience, Inc., a Minnesota corporation (the “Corporation”), DOES HEREBY CERTIFY: Pursuant to the authority expressly granted and vested in the Board of Directors of the Corporation the following resolutions were adopted |
|
| November 14, 2016 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. Exhibit 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. The Articles of Incorporation of SpectraScience, Inc., as amended, are hereby amended and restated in their entirety to read as follows: ARTICLE I. NAME AND REGISTERED OFFICE 1.1 Name. The name of this Corporation is SpectraScience, Inc. 1.2 Registered Office. The location and post office address of the registered o |
|
| November 14, 2016 |
EX-3.11 12 ex3-11.htm Exhibit 3.11 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A PREFERRED STOCK; SERIES B PREFERRED STOCK; SERIES C PREFERRED STOCK; SERIES AA, NON-TRANSFERRABLE, SUPER VOTING, PREFERRED STOCK; AND UNDESIGNATED STOCK OF SPECTRASCIENCE, INC. SpectraScience, Inc., a Minnesota corporation (the “Corporation”), DOES HEREBY CERTIFY: Pursuant to the authority expressly |
|
| October 3, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Amendment No. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. (Name |
|
| September 22, 2016 |
Exhibit 3.6 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES AA, NON-TRANSFERRABLE, SUPER VOTING, PREFERRED STOCK OF SPECTRASCIENCE, INC. SpectraScience, Inc., a Minnesota corporation (the ?Corporation?), DOES HEREBY CERTIFY: Pursuant to the authority expressly granted and vested in the Board of Directors of the Corporation the following resolutions were adopted on April 15, 2016: WHE |
|
| September 22, 2016 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2014 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| September 22, 2016 |
AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. Exhibit 3.5 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the ?Company?), hereby certifies as follows: The members of the Board of Directors have adopted a resolution amending Section 2.01 of the Amended and Restated Articles of Incorporation of the Company, an |
|
| September 22, 2016 |
September 21, 2016 Mr. Tom Jones United States Securities and Exchange Commission Washington, D.C. 20549 Re: SpectraScience, Inc. Amendment No. 1 to Preliminary Information Statement on Schedule 14C Filed September 13, 2016 File No. 000-13092 Dear Mr. Jones: Thank you for the comment and questions raised in your letter of September 19, 2016, regarding the referenced filing. In order to expedite yo |
|
| September 13, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2016 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| September 13, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Amendment No. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name |
|
| September 12, 2016 |
September 12, 2016 Mr. Tom Jones United States Securities and Exchange Commission Washington, D.C. 20549 Re: SpectraScience, Inc. (the ?Company?) Preliminary Information Statement on Schedule 14C Filed August 16, 2016 File No. 000-13092 Dear Mr. Jones: Thank you for the comments and questions raised in your letter of August 31, 2016, regarding the referenced filing. In order to expedite your revie |
|
| August 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| August 19, 2016 |
EX-99.(A)(1)(A) 2 ex-a1a.htm Exhibit (a)(1)(A) NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THIS TRANSACTION OR PASSED UPON THE MERITS OR FAIRNESS OF SUCH TRANSACTION OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE INFORMATION CONTAINED IN THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. OFFER TO EXCHANGE W |
|
| August 19, 2016 |
Exhibit (a)(1)(B) SPECTRASCIENCE, INC. OFFER TO EXCHANGE WARRANTS TO PURCHASE COMMON STOCK ISSUED BETWEEN JANUARY 27, 2012 ? MARCH 14, 2016 ELECTION FORM INSTRUCTIONS August , 2016 Dear Eligible Warrants Holder: All terms used in this Election Form but not defined herein have the meanings given to them in the ?Offer to Exchange? dated August , 2016 (the ?Offering Memorandum?). To participate in th |
|
| August 19, 2016 |
Exhibit (a)(1)(C) SPECTRASCIENCE, INC. OFFER TO EXCHANGE WARRANTS TO PURCHASE COMMON STOCK ISSUED BETWEEN JANUARY 27, 2012 ? MARCH 31, 2016 WITHDRAWAL FORM INSTRUCTIONS August , 2016 Dear Eligible Warrant Holder: All terms used in this Withdrawal Form but not defined herein have the meanings given to them in the ?Offer to Exchange? dated August , 2016 (the ?Offering Memorandum?). If the Company re |
|
| August 19, 2016 |
SC TO-I 1 formscto-i.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 SpectraScience, Inc. (Name of Subject Company (Issuer) and Name of Filing Person (Offeror)) Common Stock, Par Value $0.01 per share (Title of Class of Securities) 84760E (CUSIP Nu |
|
| August 19, 2016 |
[Letterhead of SpectraScience, Inc.] EX-99.(A)(1)(D) 5 ex-a1d.htm Exhibit (a)(1)(D) [Letterhead of SpectraScience, Inc.] August , 2016 To the Holders of Eligible Warrant(s): This letter is to inform you, as a holder of Warrant(s) to Purchase Common Stock issued between January 27, 2012 and March 14, 2016 (the “Eligible Warrant(s)”), that we are offering to exchange your Eligible Warrant(s) for: (i) the issuance of restricted shares o |
|
| August 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| August 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SPECTRASCIENCE, INC. (Name of Registrant a |
|
| August 15, 2016 |
SpectraSCIENCE (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| August 15, 2016 |
SpectraSCIENCE (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| May 20, 2016 |
SpectraSCIENCE FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction (I.R.S. Employer Identificat |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 33-24138-D CUSIP NUMBER 45247F 104 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 1 |
|
| March 30, 2016 |
SpectraSCIENCE 10-K (Annual Report) 10-K 1 s10273710k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2015 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE |
|
| January 5, 2016 |
Changes in Registrant's Certifying Accountant 8-K 1 s1024238k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4 , 2016 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Inc |
|
| January 5, 2016 |
Exhibit 16.1 January 4, 2016 U.S. Securities and Exchange Commission 100 F. Street Washington, DC 20549 ? 7561 Ladies and Gentlemen: Re: SpectraScience, Inc. Commission File No. 000-55097 We have read the statements of SpectraScience, Inc. pertaining to our firm included in Item 4.01 of the Form 8-K dated January 4, 2016 and are in agreement with the statements contained in that document pertainin |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| November 16, 2015 |
SCIE / SpectraSCIENCE, Inc. / VIS VIRES GROUP, INC. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. )* SPECTRASCIENCE, INC. (Name of issuer) Common Stock, $0.01 value per share (Title of class of securities) 84760E301 (CUSIP number) November 16, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| October 22, 2015 |
October 22, 2015 Mr. Martin James United States Securities and Exchange Commission Washington, D.C. 20549 Re: SpectraScience, Inc. Form 10-K for the year ended December 31, 2014 Forms 10-Q for the quarters ended March 31, 2015 and June 30, 2015 File Number: 000-13092 Dear Mr. James: We are responding to the Staff?s comments and questions raised in your letter of October 1, 2015, regarding the refe |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| May 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| April 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2015 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| March 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K S ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2014 £ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of regis |
|
| December 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2014 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission |
|
| November 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| August 26, 2014 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2014 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction (I.R.S. Employer Identificati |
|
| July 21, 2014 |
SCIE / SpectraSCIENCE, Inc. DEF 14A - - DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| July 9, 2014 |
SCIE / SpectraSCIENCE, Inc. PRE 14A - - PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| June 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| June 27, 2014 |
Exhibit 10.14 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between SpectraScience, Inc., a Minnesota corporation (the “Company”), and Michael Oliver (“Executive”), effective January 1, 2013 (the “Effective Date”). RECITALS WHEREAS, Executive currently is employed by SpectraScience as its President and Chief Executive Officer. WHEREAS, the Company wishes |
|
| June 27, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2013 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of regis |
|
| April 18, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| March 28, 2014 |
10-Q 1 v36142510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdicti |
|
| March 28, 2014 |
5% ORIGINAL ISSUE DISCOUNT UNSECURED CONVERTIBLE DEBENTURE DUE SEPTEMBER __, 2014 (1) Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR |
|
| March 28, 2014 |
Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of the last date set forth on the signature page hereof between SpectraScience, Inc., a Minnesota corporation (the “Company”), and the undersigned (the “Subscriber”). WITNESSETH: WHEREAS, the Company is conducting a private offering (the “Offering”) of 5% original issue discount unsecured convertible debe |
|
| March 28, 2014 |
COMMON STOCK PURCHASE WARRANT SPECTRASCIENCE, Inc. Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR H |
|
| February 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2014 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| February 7, 2014 |
February 7, 2014 Securities and Exchange Commission Washington, D.C. 20549 Commissioners: We have read SpectraScience, Inc.'s statements included under Item 4.01 of its Form 8-K filed on February 7, 2014 and we agree with such statements concerning our firm. McGladrey LLP |
|
| February 7, 2014 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2014 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State or Other Jurisdiction of Incorporation) (Commission |
|
| December 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| November 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| October 4, 2013 |
SpectraScience Appoints Lowell Giffhorn to be Chief Financial Officer EX-99.1 3 v356571ex99-1.htm EXHIBIT 99.1 SpectraScience Appoints Lowell Giffhorn to be Chief Financial Officer SAN DIEGO, October 4, 2013 (Globe Newswire) – SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company, today announced that its board of directors has appointed Lowell Giffhorn as the Company’s new Chief Financial Officer. Michael Oliver, President and Chief Executive |
|
| October 4, 2013 |
CONSULTING AGREEMENT This Consulting Agreement (“Agreement”) is between SpectraScience, Inc. |
|
| October 4, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 |
|
| September 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| September 25, 2013 |
EX-10.1 2 v355748ex10-1.htm EXHIBIT 10.1 |
|
| July 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 4 |
|
| July 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41 |
|
| June 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 4 |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-13092 NOTIFICATION OF LATE FILING CUSIP NUMBER 84760E301 (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transi |
|
| April 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2012 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of regis |
|
| April 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of (Commission File Number) (I.R. |
|
| April 5, 2013 |
Exhibit 99.1 Operator: Good morning, ladies and gentlemen, and welcome to the SpectraScience Inc. Business Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Eric Weiner from Stonegate. Eric Weiner: Thank you and good morning. Welcome to SpectraScience’s |
|
| April 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER CUSIP NUMBER (Check One): x Form 10-K ¨ Form 20-F ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR For Period Ended: December 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Repo |
|
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) |
|
| March 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) |
|
| February 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| February 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2013 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| December 31, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| December 10, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| November 15, 2012 |
COMMON STOCK PURCHASE WARRANT SPECTRASCIENCE, Inc. EXHIBIT 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HY |
|
| November 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q/A (Amendment No. 1) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of i |
|
| November 15, 2012 |
EXHIBIT 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of the last date set forth on the signature page hereof between SpectraScience, Inc., a Minnesota corporation (the “Company”), and the undersigned (the “Subscriber”). W I T N E S S E T H: WHEREAS, the Company is conducting a private offering (the “Offering”) for which Laidlaw & Company (UK) Ltd. is acting |
|
| November 15, 2012 |
5% ORIGINAL ISSUE DISCOUNT UNSECURED CONVERTIBLE DEBENTURE DUE __________, 2013 EXHIBIT 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR H |
|
| November 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-13092 NOTIFICATION OF LATE FILING CUSIP NUMBER 84760E301 (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tr |
|
| November 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| November 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| October 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| September 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numb |
|
| September 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q/A QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiz |
|
| August 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) |
|
| August 14, 2012 |
PENTAX EUROPE DISTRIBUTOR AGREEMENT EXHIBIT 10.1 PENTAX EUROPE DISTRIBUTOR AGREEMENT THIS PENTAX EUROPE DISTRIBUTOR AGREEMENT (this “Agreement”), effective this 15th day of June 2012 (the “Effective Date”), by and between SpectraScience, Inc., a Minnesota corporation with offices at 11568-11 Sorrento Valley Road, San Diego, California USA 92121 (“SpectraScience”), and PENTAX Europe GmbH organized under the laws of Germany, with offi |
|
| August 14, 2012 |
AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. EX-3.1 2 v321129ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), hereby certifies as follows: The members of the Board of Directors have adopted a resolution amending Section 2.01 of the Amended and Restated Articl |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| July 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of (Commission File Number) (I.R. |
|
| July 13, 2012 |
EX-99.1 2 v318498ex99-1.htm EXHIBIT 99.1 1 July 13, 2012 2 This presentation contains statements of a forward - looking nature which represent our management's beliefs and assumptions concerning future events . When used in this presentation, the words “believe,” “expect,” and similar expressions are intended to identify forward - looking statements, including statements regarding revenue, distrib |
|
| July 13, 2012 |
1 July 2012 2 This presentation contains statements of a forward - looking nature which represent our management's beliefs and assumptions concerning future events . |
|
| June 21, 2012 |
EX-99.1 2 v316466ex99-1.htm EXHIBIT 99.1 EXHIBIT 99.1 SpectraScience Signs Europe and Middle East Distribution Agreement with PENTAX for the WavSTAT Optical Biopsy System SAN DIEGO, June 18, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, has signed an exclusive five-year agreement with PENTAX Europe GmbH to distribute its WavSTAT Optical Biopsy Sy |
|
| June 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 4 |
|
| June 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| June 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| May 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| April 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) |
|
| March 30, 2012 |
CERTIFICATE OF REDESIGNATION OF SERIES C PREFERRED STOCK EX-3.4 2 v307140ex3-4.htm EXHIBIT 3.4 Exhibit 3.4 CERTIFICATE OF REDESIGNATION OF SERIES C PREFERRED STOCK I, Jim Dorst, Chief Financial Officer of SpectraScience, Inc., a Minnesota corporation (the “Company”), do hereby certify that on January 13, 2012, under the authority of Article II, Section 2.01 of the Company’s Amended and Restated Articles of Incorporation, the Board of Directors of the Co |
|
| March 30, 2012 |
FORM OF SUBSCRIPTION AGREEMENT Exhibit 10.10 FORM OF SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of the last date set forth on the signature page hereof between SpectraScience, Inc., a Minnesota corporation (the “Company”), and the undersigned (the “Subscriber”). WITNESSETH: WHEREAS, the Company is conducting a private offering (the “Offering”)for which Laidlaw & Company (UK) Ltd. is acting |
|
| March 30, 2012 |
Exhibit 21 SUBSIDIARIES LUMA Imaging Corporation, a Delaware Corporation SpectraScience International, Inc., a Minnesota Corporation |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2011 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of regis |
|
| March 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) |
|
| February 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numbe |
|
| January 30, 2012 |
COMMON STOCK PURCHASE WARRANT SPECTRASCIENCE, Inc. NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED E |
|
| January 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2012 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number |
|
| January 30, 2012 |
5% ORIGINAL ISSUE DISCOUNT UNSECURED CONVERTIBLE DEBENTURE DUE JULY 27, 2012 EX-4.1 2 v300748ex4-1.htm NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| September 15, 2011 | ||
| September 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2011 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Numb |
|
| September 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Amendment No. 1) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorpor |
|
| August 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| July 18, 2011 | ||
| July 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2011 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of (Commission File Number) (I.R. |
|
| June 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2011 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of (Commission File Number) (I.R. |
|
| June 22, 2011 | ||
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2011 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 4 |
|
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| June 14, 2011 |
Exhibit 99.1 Dear Shareholders, This past year was transformative for SpectraScience, culminating with our Board of Directors’ strategic decision to move our business in a new direction. As you are aware, 2010 was not without its challenges. On a macro level, healthcare service providers faced tighter budgets amidst continued uncertainty in the global healthcare market. These challenges were exace |
|
| May 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| March 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of regis |
|
| March 31, 2011 |
Exhibit 10.7 November 24, 2010 Michael P. Oliver San Diego, California 92127 Dear Michael: I am pleased to offer you a position with SpectraScience, Inc. (the “Company”), as its Chief Executive Officer. If you decide to join us, you will receive an annual salary of $225,000, which will be paid weekly in accordance with the Company’s normal payroll procedures. In addition you will be paid cash bonu |
|
| March 1, 2011 |
SPECTRASCIENCE, INC. 2011 EQUITY INCENTIVE PLAN SECTION 1. SPECTRASCIENCE, INC. 2011 EQUITY INCENTIVE PLAN SECTION 1. DEFINITIONS As used herein, the following terms shall have the meanings indicated below: (a) “Administrator” shall mean the Board of Directors of the Company, or one or more Committees appointed by the Board, as the case may be. (b) “Affiliate(s)” shall mean a Parent or Subsidiary of the Company. (c) “Award” shall mean any grant of an Opti |
|
| March 1, 2011 |
POWER OF ATTORNEY For Executing Forms 3, 4 and 5 The undersigned hereby constitutes and appoints James Dorst, Ryan C. |
|
| March 1, 2011 |
NONQUALIFIED STOCK OPTION AGREEMENT SPECTRASCIENCE, INC. 2011 EQUITY INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT SPECTRASCIENCE, INC. 2011 EQUITY INCENTIVE PLAN THIS AGREEMENT, made effective as of this day of , 20, by and between SpectraScience, Inc., a Minnesota corporation (the “Company”), and (“Participant”). WITNESSETH: WHEREAS, Participant on the date hereof is a key employee, officer, director of or consultant or advisor to the Company or one of its Subsidiaries; an |
|
| March 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2011 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of incorporation) (Commission |
|
| February 15, 2011 |
POWER OF ATTORNEY For Executing Forms 4 and 5 The undersigned hereby constitutes and appoints James Dorst, Ryan C. |
|
| February 10, 2011 |
11568-11 Sorrento Valley Road San Diego, California 92121 11568-11 Sorrento Valley Road San Diego, California 92121 February 10, 2011 VIA EDGAR AND FEDEX Ms. |
|
| January 27, 2011 |
11568-11 Sorrento Valley Road San Diego, California 92121 January 27, 2011 VIA EDGAR AND FEDEX Ms. |
|
| December 13, 2010 |
Fredrikson & Byron, P.A. 200 South Sixth Street, Suite 4000 Minneapolis, MN 55402 www.fredlaw.com Direct: (612) 492-7252 Main: (612) 492-7000 Fax: (612) 492-7077 Email: [email protected] December 13, 2010 VIA EDGAR AND FEDEX Ms. Tara L. Harkins Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: SpectraScience, Inc. Form 10-K for the Year |
|
| December 10, 2010 |
POWER OF ATTORNEY For Executing Forms 3, 4 and 5 The undersigned hereby constitutes and appoints James Dorst, Ryan C. |
|
| December 1, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2010 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 |
|
| December 1, 2010 |
SpectraScience Announces Appointment of Michael Oliver as President and Chief Executive Officer SpectraScience Announces Appointment of Michael Oliver as President and Chief Executive Officer SAN DIEGO, December 1, 2010 (Marketwire) – SpectraScience, Inc. |
|
| November 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or orga |
|
| October 25, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2010 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 ( |
|
| October 25, 2010 |
SpectraScience Announces Strategic Restructuring of Business SpectraScience Announces Strategic Restructuring of Business SAN DIEGO, October 25, 2010 (Marketwire) – SpectraScience, Inc. |
|
| October 13, 2010 |
SpectraScience Names New Chairman of the Board SpectraScience Names New Chairman of the Board SAN DIEGO, October 13, 2010 (MARKETWIRE) – SpectraScience, Inc. |
|
| October 13, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2010 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 (I |
|
| September 10, 2010 |
PROSPECTUS SPECTRASCIENCE, INC. 25,225,849 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) File No. 333-167826 PROSPECTUS SPECTRASCIENCE, INC. 25,225,849 Shares of Common Stock This Prospectus relates to the sale of up to 25,225,849 shares of SpectraScience, Inc. common stock, par value $0.01 per share, the (“Common Stock”), which include: · 15,766,155 shares of Common Stock underlying a like number of shares of Series C Convertible Preferred Stock; · 7, |
|
| September 9, 2010 |
September 9, 2010 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Celia A. Soehner, Attorney Re: SpectraScience, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-167826 Dear Ms. Soehner: On behalf of the Company, the undersigned respectfully requests that the above-referenced Registration S |
|
| September 2, 2010 |
PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-164430 PROSPECTUS SUPPLEMENT NO. 2 (TO PROSPECTUS DATED February 12, 2010, as updated and supplemented by Post-Effective Amendment No. 1 dated May 11, 2010) PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock This prospectus, as updated and supplemented by Post-Effective Amendment No. 1 (collectively, the “Prospectus”), |
|
| August 26, 2010 |
SPECTRASCIENCE, INC. Maximum of 25,000,000 Shares ($5,000,000) SELECTED DEALERS AGREEMENT EXHIBIT 10.5 SPECTRASCIENCE, INC. Maximum of 25,000,000 Shares ($5,000,000) SELECTED DEALERS AGREEMENT As of July 2, 2009 Dear Sirs: SpectraScience, Inc. (the “Company”) is offering for sale the shares of common stock (the “Shares”) and warrants to purchase common stock (the “Warrants”, together with the Shares, the “Units”) pursuant to the Company’s Confidential Private Placement Memorandum dated |
|
| August 26, 2010 |
Registration No. 333-167826 As filed with the U.S. Securities and Exchange Commission on August 26, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdiction of incor |
|
| August 26, 2010 |
EXHIBIT 4.6 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT THERETO, OR (2)RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL TO THE COMPANY TO THE |
|
| August 26, 2010 |
SPECTRASCIENCE, INC. Maximum of 25,000,000 Shares ($5,000,000) SELECTED DEALERS AGREEMENT EXHIBIT 10.6 SPECTRASCIENCE, INC. Maximum of 25,000,000 Shares ($5,000,000) SELECTED DEALERS AGREEMENT As of April 6, 2010 Dear Sirs: SpectraScience, Inc. (the “Company”) is offering for sale the shares of common stock (the “Shares”) and warrants to purchase common stock (the “Warrants”, together with the Shares, the “Units”) pursuant to the Company’s Confidential Private Placement Memorandum date |
|
| August 26, 2010 |
[Fredrikson & Byron Letterhead] [Fredrikson & Byron Letterhead] Fredrikson & Byron, P.A. 200 South Sixth Street, Suite 4000 Minneapolis, MN 55402 www.fredlaw.com Direct: (612) 492-7252 Main: (612) 492-7000 Fax: (612) 492-7077 Email: [email protected] August 26, 2010 VIA EDGAR AND FEDEX Ms. Celia A. Soehner Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: SpectraScienc |
|
| August 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organizat |
|
| August 5, 2010 |
[Fredrikson & Byron Letterhead] [Fredrikson & Byron Letterhead] Fredrikson & Byron, P.A. 200 South Sixth Street, Suite 4000 Minneapolis, MN 55402 www.fredlaw.com Direct: (612) 492-7252 Main: (612) 492-7000 Fax: (612) 492-7077 Email: [email protected] August 5, 2010 VIA EDGAR AND FEDEX Ms. Celia A. Soehner Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: SpectraScience |
|
| August 5, 2010 |
Registration No. 333-167826 As filed with the U.S. Securities and Exchange Commission on August 5, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdiction of incorp |
|
| June 28, 2010 |
Registration No. 333- As filed with the U.S. Securities and Exchange Commission on June 28, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdiction of incorporation or organization) ( |
|
| June 24, 2010 |
EXHIBIT 4.6 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES C PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), in accordance with the provisions of Minnesota Statutes, Sectio |
|
| June 24, 2010 |
EXHIBIT 4.5 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT THERETO, OR (2)RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL TO THE COMPANY TO THE |
|
| June 24, 2010 |
EXHIBIT 4.4 FORM OF SUBSCRIPTION AGREEMENT IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN SpectraScience, Inc. , 2010 11568-11 Sorrento Valley Rd. San Diego, CA 92121 Gentlemen: The undersigned, (“Investor”) hereby tenders this subscription and applies for the purchase of Units (the “Securities”) of SpectraScience, Inc. (the “Company”) at $10.00 p |
|
| June 24, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2010 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 (I.R |
|
| June 4, 2010 |
POWER OF ATTORNEY The undersigned hereby constitutes and appoints James Hitchin, James Dorst and Scott J. |
|
| May 28, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2010 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 (I.R. |
|
| May 28, 2010 |
Exhibit 99.1 SpectraScience Appoints Sheldon L. Miller Esq. to Its Board of Directors SAN DIEGO, CA-(Marketwire - May 26, 2010) - SpectraScience, Inc. (OTCBB: SCIE), a San Diego based medical device company, announced today that it has appointed Sheldon L. Miller Esq. to its Board of Directors. Jim Hitchin, SpectraScience's CEO, said, "We are extremely pleased that Mr. Miller has accepted a positi |
|
| May 20, 2010 |
PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock 424B3 1 v185914424b3.htm Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-164430 PROSPECTUS SUPPLEMENT NO. 1 (TO PROSPECTUS DATED February 12, 2010, as updated and supplemented by Post-Effective Amendment No. 1 dated May 11, 2010) PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock This prospectus, as updated and supplemented by Post-Effective Amendment No. 1 (collecti |
|
| May 18, 2010 |
PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock 424B3 1 v185830424b3.htm Filed Pursuant to Rule 424(b)(3) File No. 333-164430 PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock This Prospectus relates to the sale of up to 40,249,213 shares of SpectraScience, Inc. common stock, par value $0.01 per share, the (“Common Stock”), which include: · 25,000,000 shares of Common Stock underlying a like number of shares of Series B Converti |
|
| May 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010 Commission file number 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1448837 (State or other jurisdiction of incorporation or organiza |
|
| May 11, 2010 |
Registration No. 333-164430 As filed with the U.S. Securities and Exchange Commission on May 11, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdict |
|
| May 11, 2010 |
CERTIFICATE OF DESIGNATION OF COMMON STOCK EXHIBIT 4.7 CERTIFICATE OF DESIGNATION OF COMMON STOCK I, James Hitchin, Chief Executive Officer of SpectraScience, Inc., a Minnesota corporation (the “Company”), do hereby certify that on April 9, 2010, under the authority of Article II, Section 2.01 of the Company’s Amended and Restated Articles of Incorporation (the “Articles”), the Board of Directors of the Company unanimously adopted a resolu |
|
| May 11, 2010 |
EXHIBIT 4.6 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES C PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), in accordance with the provisions of Minnesota Statutes, Sectio |
|
| March 31, 2010 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Exact name of registrant as speci |
|
| February 12, 2010 |
PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) File No. 333-164430 PROSPECTUS SPECTRASCIENCE, INC. 40,249,213 Shares of Common Stock This Prospectus relates to the sale of up to 40,249,213 shares of SpectraScience, Inc. common stock, par value $0.01 per share, the (“Common Stock”), which include: · 25,000,000 shares of Common Stock underlying a like number of shares of Series B Convertible Preferred Stock; · 12 |
|
| February 11, 2010 |
February 11, 2010 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Celia A. Soehner, Attorney Re: SpectraScience, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-164430 Dear Ms. Soehner: On behalf of the Company, the undersigned respectfully requests that the above-referenced Registration S |
|
| February 10, 2010 |
February 10, 2010 VIA EDGAR AND FACSIMILE U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Celia A. Soehner, Attorney Re: SpectraScience, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-164430 Dear Ms. Soehner: On behalf of the Company, the undersigned respectfully requests that the above-referenced |
|
| February 8, 2010 |
Registration No. 333-164430 As filed with the U.S. Securities and Exchange Commission on February 8, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pre-Effective Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisd |
|
| February 3, 2010 |
Registration No. 333-164430 As filed with the U.S. Securities and Exchange Commission on February 2, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pre-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisd |
|
| February 3, 2010 |
Sincerely, /s/ Jim Hitchin Jim Hitchin Chairman and Chief Executive Officer (858) 847-0200 February 2, 2010 Via EDGAR and Facsimile Ms. Celia A. Soehner, Attorney United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: SpectraScience, Inc. Registration Statement on Form S-1 Filed on January 20, 2010 File No. 333-164430 Dear Ms. Soehner: SpectraScience, Inc. (the “Company”) submits this letter in response to comments |
|
| January 20, 2010 |
EXHIBIT 21.1 SUBSIDIARIES Luma Imaging Corporation, a Delaware Corporation, wholly owned by the Registrant. |
|
| January 20, 2010 |
As filed with the U.S. Securities and Exchange Commission on January 20, 2010 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdiction of incorporation or organization |
|
| December 21, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2009 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-14 |
|
| November 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, |
|
| November 16, 2009 |
CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. EXHIBIT 3.3 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF SPECTRASCIENCE, INC. The undersigned, being the Chief Executive Officer of SpectraScience, Inc., a Minnesota corporation (the “Corporation”), in accordance with the Minnesota Business Corporation Act, does hereby certify that the Board of Directors adopted the following resolutions effective as of September 21, 2009: AMENDMENT OF |
|
| November 6, 2009 |
EXHIBIT 4.5 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT THERETO, OR (2)RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL TO THE COMPANY TO THE |
|
| November 6, 2009 |
EXHIBIT 4.4 SUBSCRIPTION AGREEMENT IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN SpectraScience, Inc. 11568-11 Sorrento Valley Rd. San Diego, CA 92121 Gentlemen: The undersigned, (“Investor”) hereby tenders this subscription and applies for the purchase of Units (the “Securities”) of SpectraScience, Inc. (the “Company”) at $10.00 per unit. The ag |
|
| November 6, 2009 |
EXHIBIT 4.6 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), in accordance with the provisions of Minnesota Statutes, Sectio |
|
| November 6, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2009 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-144 |
|
| August 21, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| August 14, 2009 |
Exhibit 4.4 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B PREFERRED STOCK OF SPECTRASCIENCE, INC. (PURSUANT TO MINNESOTA STATUTES, SECTION 302A.401, SUBD. 3(B)) The undersigned, being the Secretary of SpectraScience, Inc., a corporation organized and existing under the laws of the State of Minnesota (the “Company”), in accordance with the provisions of Minnesota Statutes, Sectio |
|
| August 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc. |
|
| August 14, 2009 |
Exhibit 4.5 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT THERETO, OR (2)RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL TO THE COMPANY TO THE |
|
| August 4, 2009 |
EXHIBIT 99.1 F. Duwaine Townsen Joins SpectraScience Board of Directors SAN DIEGO, July 28 /PRNewswire-FirstCall/ - SpectraScience, Inc. (OTC Bulletin Board: SCIE - News), a San Diego based medical device company, today announced that F. Duwaine Townsen, Co-Founder/Managing Director of EndPoint Late-Stage Fund has joined its Board of Directors. He began his career with Arthur Young & Company follo |
|
| August 4, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2009 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-144883 |
|
| August 4, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 22, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2009 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-1448837 |
|
| May 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc |
|
| April 30, 2009 |
EXHIBIT 21.1 SUBSIDIARIES Luma Imaging Corporation, a Delaware Corporation, wholly owned by the Registrant. |
|
| April 30, 2009 |
FORM OF DIRECTORS’ OPTION AGREEMENT STOCK OPTION AGREEMENT EXHIBIT 10.1 FORM OF DIRECTORS’ OPTION AGREEMENT STOCK OPTION AGREEMENT THIS AGREEMENT, made this day of 200, by and between SpectraScience, Inc., a Minnesota corporation (the "Company”) and ("Optionee"). 1. Grant of Option. Pursuant to its Amended 2001 Stock Option Plan (the "Plan), the Company hereby grants to Optionee, on the date set forth above, the right and option (hereinafter called the "o |
|
| April 30, 2009 |
As filed with the U.S. Securities and Exchange Commission on April 29, 2009 As filed with the U.S. Securities and Exchange Commission on April 29, 2009 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 3845 94-3096597 (State or other jurisdiction of incorporation or organization) |
|
| April 30, 2009 |
EXHIBIT 3.2 SPECTRASCIENCE, INC AMENDED BYLAWS ARTICLE I OFFICERS, CORPORATE SEAL AND SHAREHOLDER CONTROL AGREEMENT SECTION 1.01. REGISTERED AND OTHER OFFICES. The registered office of the corporation in Minnesota shall be that set forth in the Articles of Incorporation or statement of the Board of Directors filed with the Secretary of State of Minnesota changing the registered office in the manne |
|
| March 30, 2009 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Name of small business issuer in |
|
| February 4, 2009 |
COMMON STOCK PURCHASE AGREEMENT EXHIBIT 10.1 EXECUTION COPY COMMON STOCK PURCHASE AGREEMENT COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of January 30, 2009 by and between SPECTRASCIENCE, INC., a Minnesota corporation (the “Company”), and FUSION CAPITAL FUND II, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof. |
|
| February 4, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2009 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-144 |
|
| February 4, 2009 |
EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of January 30, 2009, by and between SPECTRASCIENCE, INC., a Minnesota corporation, (the "Company"), and FUSION CAPITAL FUND II, LLC (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the |
|
| December 12, 2008 |
11568-11 Sorrento Valley Road San Diego, California 92121 11568-11 Sorrento Valley Road San Diego, California 92121 December 12, 2008 Via Edgar and Fax (202) 772-9218 Mr. |
|
| November 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, |
|
| August 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc. |
|
| May 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc |
|
| May 2, 2008 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2008 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State or Other Jurisdiction of Incorporation) 0-13092 41-1448837 (Commission File No.) (IRS Emp |
|
| May 2, 2008 |
Exhibit 16.1 May 1, 2008 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: SpectraScience, Inc. Commission File No. 0-13902 Ladies and Gentlemen: We have read Item 4.01 included in the Form 8-K dated April 28, 2008 of SpectraScience, Inc. which we understand will be filed with the Securities and Exchange Commission and are in agreement |
|
| April 8, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 31, 2008 |
Exhibit 4.3 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF1933 (THE "ACT") NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT THERETO, OR (2)RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL TO THE COMPANY TO THE |
|
| March 31, 2008 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Development Stage En |
|
| March 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| December 11, 2007 |
Jim Dorst joins SpectraScience as CFO EXHIBIT 99.1 FOR IMMEDIATE RELEASE Jim Dorst joins SpectraScience as CFO December 10, 2007 San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that Jim Dorst has joined the Company as its Vice President of Finance and Chief Financial Officer. Jim Hitchin the Company’s CEO said, “Jim comes to us with many years of experience in public medical device, manufacturing and software firms. His e |
|
| December 11, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2007 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-144 |
|
| November 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission file number 0-13092 SPECTRASCIENCE, |
|
| November 13, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 6, 2007 (Date of earliest event reported) SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 41-1448837 (Commi |
|
| November 13, 2007 |
Table of Contents EXHIBIT 2.1 STOCK PURCHASE AGREEMENT BY AND AMONG SPECTRASCIENCE, INC. AND EUCLID PARTNERS IV, L.P., EUCLIDSR PARTNERS, L.P., EUCLIDSR BIOTECHNOLOGY PARTNERS, L.P., STEPHEN L. WATSON AND ROSS FLEWELLING STOCK PURCHASE AGREEMENT This Agreement (the “Agreement”) is entered into as of November 6, 2007, by and among SpectraScience, Inc., a Minnesota corporation (the “Buyer”) and Eucl |
|
| November 13, 2007 |
SpectraScience Acquires Luma Imaging Corporation PRESS RELEASE SpectraScience Acquires Luma Imaging Corporation November 8, 2007 San Diego, CA SpectraScience, Inc. |
|
| October 18, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 17, 2007 (Date of earliest event reported) SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 41-1448837 (Commi |
|
| October 1, 2007 |
Exhibit 99.1 PRESS RELEASE SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors FOR IMMEDIATE RELEASE September 25, 2007 San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that it has elected the Honorable Tommy Thompson to its Board of Directors. Before entering the private sector in 2005, Secretary Thompson enjoyed a long and distinguished career in public ser |
|
| October 1, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2007 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota 000-13092 41-1448837 (State of other jurisdiction of incorporation) (Commission File N |
|
| August 14, 2007 |
Exhibit 4.2 STOCK PURCHASE WARRANT To Purchase Series A Preferred Stock of SPECTRASCIENCE, INC. THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) NOR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNTIL (1) A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAW HAS BECOME EFFECTIVE WITH RESPECT |
|
| August 14, 2007 |
CERTIFICATE OF CREATION OF SERIES A PREFERRED STOCK SPECTRASCIENCE, INC. Exhibit 4.1 CERTIFICATE OF CREATION OF SERIES A PREFERRED STOCK OF SPECTRASCIENCE, INC. I, James Hitchin, Chief Executive Officer of SpectraScience, Inc. a Minnesota corporation (the “Company”), do hereby certify that on June 12, 2007, under the authority of Article II, Section 2.01 of the Company's Amended and Restated Articles of Incorporation, the Board of Directors of the Company unanimously a |
|
| August 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc. |
|
| June 25, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2007 SPECTRASCIENCE, INC. (Exact name of registrant as specified in its charter) Minnesota (State of other jurisdiction of incorporation) 000-13092 (Commission File Number) 41-144883 |
|
| June 25, 2007 |
Exhibit 99.1 PRESS RELEASE SpectraScience Appoints John Pappajohn to Board of Directors FOR IMMEDIATE RELEASE June 18, 2006 San Diego, CA SpectraScience, Inc. (SCIE.OB) announced today that it has elected John Pappajohn to its Board of Directors. Mr. Pappajohn is a long time health care venture capital investor based in Des Moines, Iowa. Since 1969, Mr. Pappajohn has been the President and princip |
|
| May 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc |
|
| March 28, 2007 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: DECEMBER 31, 2006 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-13092 SPECTRASCIENCE, INC. (Development Stage En |
|
| November 14, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2006 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, |
|
| August 16, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB/A (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE |
|
| August 11, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedJune 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission file number 0-13092 SPECTRASCIENCE, In |
|
| May 12, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2006 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-13092 SPECTRASCIENCE, Inc |
|
| March 31, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB Back to Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 31, 2006 |
SpectraScience, Inc. Code of Ethics EXHIBIT 14 SpectraScience, Inc. Code of Ethics This Code of Ethics is approved by the Board of Directors and applies to all employees, and officers and directors of the Company. It contains standards necessary to promote: honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, and full, fair, accurate, |
